Boston Scientific (BSX) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $44.60 -1.2%
Revenue Growth %: +6.1%
Financial Fact:
Income tax expense: 29M
Today's EPS Names:
CRMT, PKE, More
Revenue Growth %: +6.1%
Financial Fact:
Income tax expense: 29M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q2 EPS of $0.08, $0.10 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $2 billion versus the consensus estimate of $1.73 billion.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- ArcelorMittal (MT:NA) (MT) PT Raised to EUR65 at Jefferies
- Morgan Stanley Resumes Urban Outfitters, Inc. (URBN) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
